Recent Finacing
Recent Raise
Combioxin SA develops non-antibiotic therapeutics targeting bacterial infections and antibiotic resistance, developing CAL02—an investigational agent in clinical trials for hospitalized patients with severe pneumonia.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor